TerrAscend Stock Forecast, Price & News

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TerrAscend in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TerrAscend stock.
View analyst ratings for TerrAscend or view top-rated stocks.

Wall Street analysts have given TerrAscend a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but TerrAscend wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

TerrAscend saw a increase in short interest in the month of May. As of May 28th, there was short interest totaling 116,800 shares, an increase of 46.5% from the May 13th total of 79,700 shares. Based on an average daily volume of 216,100 shares, the days-to-cover ratio is currently 0.5 days.
View TerrAscend's Short Interest.

TerrAscend is scheduled to release its next quarterly earnings announcement on Wednesday, August 18th 2021.
View our earnings forecast for TerrAscend.

TerrAscend Corp. (OTCMKTS:TRSSF) released its quarterly earnings results on Tuesday, May, 18th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by $0.10.
View TerrAscend's earnings history.

TerrAscend's stock was trading at $1.8277 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TRSSF stock has increased by 454.8% and is now trading at $10.14.
View which stocks have been most impacted by COVID-19.

6 equities research analysts have issued twelve-month target prices for TerrAscend's stock. Their forecasts range from $13.50 to $24.00. On average, they expect TerrAscend's share price to reach $18.54 in the next year. This suggests a possible upside of 82.9% from the stock's current price.
View analysts' price targets for TerrAscend or view top-rated stocks among Wall Street analysts.

Some companies that are related to TerrAscend include (THCX.V) (THCX), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF) and Chalice Brands (GLDFF).
View all of TRSSF's competitors.

TerrAscend trades on the OTCMKTS under the ticker symbol "TRSSF."

Shares of TRSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TRSSF stock can currently be purchased for approximately $10.14.

The official website for TerrAscend is www.terrascend.com.

The company can be reached via phone at 855-837-7295.